TLR3 and inflammatory response: In vivo studies using mice demonstrated that nasally administered poly(I:C) results in TLR3- and CXCR2-dependent neutrophilic pulmonary inflammation, bronchiolar epithelial hypertrophy, interstitial edema and altered lung function [13, 14].